An Open Access Journal
2023 Impact Factor: 1.1
2023 CiteScore: 1.9
ISSN: 2717-3593
Research
not a Cost, but an Investment
Editor-in-Chief:
Mohammad Jalili, MD
Chairman:
Hooman Hossein-Nejad, MD
Peer Review Process
Peer review process helps editors select manuscripts suitable for publication. Reviewers can advise editors, but the editor-in chief (or his deputy) makes the final decision regarding the acceptance of the submitted manuscript. Decisions may also be made based on issues other than the quality of the manuscript, such as suitability for the journal readership. The editor-in-chief may reject any article at any time before publication, including after acceptance, if concerns arise about the integrity of the work. If any concerns are raised regarding an article after its publication and the corresponding author is unable to provide an appropriate and justifiable answer, that article will be marked as retracted. Therefore, it is strongly recommended that authors be extremely careful in preserving the relevant data, or send the final data used to write the paper to the journal as supplementary data from the beginning and at the time of submitting the article.
Manuscripts selected for peer review will be refereed by at least two reviewers (one clinician and one methodologist) within four weeks according to the specific criteria including the research reporting guidelines for different study designs; including CONSORT for randomized trials, STROBE for observational studies, PRISMA for systematic reviews and meta-analyses, and STARD for studies of diagnostic accuracy. Authors are advised to send their revised manuscripts within 2 weeks and if the revised version is not uploaded within 2 months, the submission will be automatically archived. The journal do not ask for any fees or charges for manuscript processing and publishing from non-Iranian authors.
Editorial Independence
The editor-in-chief makes the final decision regarding publication or rejection of the submitted manuscripts without interference of its owner (Emergency Medicine Department of Tehran University of Medical Sciences) or other authorities or sources of economic interest.
Plagiarism
Definition: When an author tries to present the work of someone else as his or her own, it is called plagiarism. In addition, when an author uses a considerable portion of his or her own previously published work in a new one without properly citing the reference, it is called a duplicate publication; sometimes also referred to as self-plagiarism. This may range from publishing the same article in another journal to 'salami-slicing', which is data segmentation, to adding little new data to the previous article.
Policy: The editorial team/reviewers of “Frontiers in Emergency Medicine” will check the submitted manuscripts for plagiarism twice (once after submission and once before publication) using available plagiarism detection software such as iThenticate. If suspected plagiarism is found in an article either before (by reviewers or editorial team) or after (by publisher or readers) publication, the journal will act according to COPE’s code of conduct and flowcharts.
Open Access Policy and Article Processing Charges
Making research freely available supports a greater global exchange of knowledge; Therfore, "Frontiers in Emergency Medicine" provides immediate open access to its content without receiving any article processing charge (APC) for authors with non-Iranian nationality.
* Note to Iranian authors:
Following acceptance, an Article Processing Charge must be paid by all Iranian authors according the table below (Revised from January 1, 2023). Due to the problems of transferring funds from foreign countries to Iran, which arise from existing international economic sanctions against Iran, the journal offers a waiver of APC to authors from all other nationalities, so the whole process is still free of charge for non-Iranian authors.
Article type |
Iranian Rials |
Review Article |
40,000,000 |
Research Article |
35,000,000 |
Brief Report |
30,000,000 |
Case Report |
20,000,000 |
Other types |
10,000,000 |
Complaints Process
All authors can submit their complaint regarding journal’s process via fem@tums.ac.ir, if any.
An Open Access Journal
2023 Impact Factor: 1.1
2023 CiteScore: 1.9
ISSN: 2717-3593
Research
not a Cost, but an Investment
Editor-in-Chief:
Mohammad Jalili, MD
Chairman:
Hooman Hossein-Nejad, MD
All the work in this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |